CD8A and neoplasm: Notably, in a mouse model of LC, co-administration of PI3Kδ-specific inhibitors and tumor-specific vaccines reduced the number of inhibitory Tregs within the tumor microenvironment and increased the number of vaccine-induced CD8+ T cells, enhancing anti-tumor efficacy (Ahmad et al., 2017).